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Association of Serum Retinol Binding Protein 4 with Adiposity 
and Pubertal Development in Korean Children and Adolescents
Retinol binding protein 4 (RBP4) has been postulated to provide a new link between obesity 
and insulin resistance. We aimed to assess the relationship between serum RBP4 and 
insulin resistance by investigating serum RBP4 levels in children and adolescents according 
to degree of obesity and pubertal stage. A total of 103 (30 lean, 39 overweight, 34 obese) 
were evaluated for serum RBP4, adiponectin, insulin, glucose and lipid profiles. RBP4 
levels of obese and overweight groups were higher than those of lean group. RBP4 level 
was higher in pubertal group than in prepubertal group. RBP4 was positively correlated 
with age, height, weight, body mass index (BMI), abdominal circumference, systolic blood 
pressure, fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), 
total cholesterol and triglyceride, and inversely with adiponectin. In the multiple linear 
regression analysis, RBP4 was found to be independently associated with pubertal stage, 
BMI and triglyceride but not with HOMA-IR. In conclusion, serum RBP4 level is related 
with degree of adiposity and pubertal development. The association of RBP4 with insulin 
resistance is supposed to be secondary to the relation between RBP4 and adipose tissue in 
children and adolescents.
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Adipose tissue is now considered an active and complex meta-
bolic endocrine organ (1). Adipose tissue secretes various adi-
pokines that play important roles in the modulation of a variety 
of biological functions. Retinol binding protein 4 (RBP4), a new-
ly discovered adipokine, is the major transport protein for reti-
nol and is strongly expressed in the liver, but also secreted by 
adipocytes (2). RBP4 has recently been proposed as a new po-
tential link between obesity and insulin resistance (3). Injection 
of purified RBP4 into mice or transgenic overexpression of RBP4 
in mice impairs insulin signaling in muscle tissue and induces 
the expression of the gluconeogenic enzyme phosphoenolpyr-
uvate carboxykinase in the liver (3). Conversely, lowering RBP4 
by genetic knockout improves insulin sensitivity in mice (3).
  Several clinical studies in adults confirmed this association 
(4-7). Interventions that can improve insulin sensitivity, includ-
ing exercise, may lower serum RBP4 levels in adults (8, 9). In con-
trast, other studies have found no links between RBP4 levels, 
obesity and insulin resistance (10, 11). A few studies in children 
and adolescents, also reported controversial findings concern-
ing the biological functions of RBP4 in obesity (12-14). Park et 
al. (15) have reported an association between RBP4 and pulmo-
nary function in prepubertal male asthmatics. Recent twin stud-
ies suggested that serum RBP4 increased with age and that the 
association of RBP4 with insulin resistance is secondary and non-
casual (16). Hence, it remains unclear, whether RBP4 causes or 
reflect obesity-related insulin resistance. 
  In this study, we aimed to assess potential casual relationship 
between serum RBP4 and obesity-related insulin resistance by 
investigating serum RBP4 levels according to degree of obesity 
and pubertal stage and the relationship between serum RBP4 
levels and other metabolic or cardiovascular parameters in Ko-
rean children and adolescents. 
MATERIALS AND METHODS
We recruited children and adolescents who visited Pediatric 
Endocrinology Clinic at Korea University Ansan Hospital in Ko-
rea. Only healthy children and adolescents were included in this 
study. No participant had cardiovascular disease, diabetes, hy-
pertension or other endocrine disorder according to medical 
histories and physical examinations that were completed prior 
to participation in this study. 
  Anthropometric measurements were taken with the subjects 
lightly clothed and without shoes. Height was measured to the 
nearest 0.1 cm using a rigid stadiometer. Weight was measured 
to the nearest 0.1 kg using a calibrated balance scale. Body mass Rhie YJ, et al.  •  Serum Retinol Binding Protein 4 in Korean Children and Adolescents
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index (BMI) was calculated as the weight in kilograms divided 
by the square of the height in meters. All subjects were divided 
into three groups (lean, overweight, and obese) according to 
degree of obesity. Obese subjects were defined as having a BMI 
greater than or equal to the 95th percentile for their age and sex 
according to 2007 Korean national growth chart. Overweight 
subjects were defined as having a BMI greater than or equal to 
the 85th percentile but less than the 95th percentile. Lean sub-
jects were defined as having a BMI less than the 75th percentile. 
Abdominal circumference was measured at the midpoint be-
tween the lower border of the rib cage and the iliac crest. Sys-
tolic and diastolic blood pressures (BP) were measured twice 
on the right arm after a 10 min rest in the supine position. 
  The pubertal stage of each participant was determined by a 
pediatric endocrinologist and rated according to the Tanner cri-
teria (17). All subjects were divided into three groups (prepu-
berty, early and late puberty) according to their pubertal stage. 
Prepubertal subjects were defined as having sexual maturity 
rating (SMR) 1. Early pubertal subjects were defined as having 
SMR 2 or 3. Late pubertal subjects were defined as having SMR 
4 or 5.
  Blood sampling was performed after an eight hour overnight 
fast. We measured serum insulin, glucose, total cholesterol, tri-
glyceride, LDL-cholesterol and HDL-cholesterol. RBP4 levels 
were measured with an enzyme immunoassay kit (AdipoGen, 
Inc., Seoul, Korea). Adiponectin levels were measured using a 
radioimmune assay kit (Linco Research Inc., St. Charles, MO, 
USA). Insulin resistance was estimated using the homeostatic 
model assessment of insulin resistance (HOMA-IR). The equa-
tion used was: HOMA-IR = (insulin [mU/L] × glucose [mM/L])/ 
22.5.
  Data are expressed as mean ± standard deviation (SD). For 
comparison of continuous clinical and metabolic variables be-
tween two groups, either independent t-test or Mann-Whitney 
U test, and among three groups, ANOVA’s test and for categori-
cal variables, chi-square test were used. Pearson’s correlation 
coefficients were calculated to evaluate the relationship between 
serum RBP4 levels and other clinical and metabolic variables. 
Multiple linear regression analysis was performed to investigate 
whether age, sex, pubertal stage, BMI, systolic BP, triglyceride, 
and HOMA-IR determine RBP4 independently. SPSS 16.0 soft-
ware was used for the statistical analyses. P value < 0.05 was con-
sidered as statistically significant.
Ethics statement
This study was approved by the Institutional Review Board of 
Korea University Ansan Hospital (IRB number AS0740). Written 
informed consent was obtained from each subject and his or 
her parents.
RESULTS
Sixty-one boys and forty-two girls between the ages of 6 and 18 yr 
were included in this study. There was no significant difference 
in serum RBP4 between male and female (54.94 ± 20.18 vs 49.67 
± 16.66 mg/L, P = 0.166). 
  The clinical and metabolic variables of lean (n = 30), over-
weight (n = 39) and obese (n = 34) groups are shown in Table 1. 
Obese group had significantly higher weight, BMI, abdominal 
circumference, fasting insulin, and HOMA-IR than those of over-
Table 1. Clinical and metabolic variables of lean, overweight and obese groups
Variables Lean (n = 30) Overweight (n = 39) Obese (n = 34) P value
Age (yr) 11.7 ± 2.1 12.8 ± 2.7 12.7 ± 2.9 0.169
Male (%) 56.7 56.4 64.7 0.729
Prepuberty (%) 46.7 41.0 26.5 0.220
Height (cm) 147.0 ± 14.0 154.1 ± 16.2 156.2 ± 15.9 0.052
Weight (kg)   41.8 ± 13.3    57.6 ± 16.0*      70.1 ± 19.9*
,† < 0.001
BMI (kg/m
2) 18.9 ± 3.0  23.6 ± 2.4*    28.0 ± 3.5*
,† < 0.001
Abdominal circumference (cm) 65.9 ± 9.6  81.0 ± 9.1*      90.3 ± 10.2*
,† < 0.001
Systolic BP (mmHg) 105.7 ± 10.6 109.1 ± 10.8  112.7 ± 13.3* 0.039
Diastolic BP (mmHg) 61.6 ± 8.4   63.8 ± 12.1 66.3 ± 9.6 0.163
RBP4 (mg/L)   41.14 ± 21.30    55.10 ± 14.94*    60.44 ± 16.13* < 0.001
Fasting glucose (mM/L)   5.07 ± 0.47   4.94 ± 0.42   4.91 ± 0.47 0.356
Fasting insulin (mIU/L)   9.80 ± 5.81 10.07 ± 6.90    14.53 ± 9.52*
,† 0.028
HOMA-IR   2.22 ± 1.44   2.23 ± 1.58      3.25 ± 1.39*
,† 0.048
Adiponectin (ng/mL) 21.37 ± 15.9   20.75 ± 15.87 18.22 ± 8.54 0.477
Total cholesterol (mg/dL) 146.9 ± 29.5 163.0 ± 35.0  165.5 ± 27.3* 0.039
Triglyceride (mg/dL)   87.2 ± 47.4 106.8 ± 51.3 108.2 ± 50.9 0.245
HDL-cholesterol (mg/dL)   44.2 ± 17.5 50.7 ± 8.6 46.8 ± 9.9 0.098
LDL-cholesterol (mg/dL)   71.9 ± 24.1    92.3 ± 28.9*    96.1 ± 26.6* 0.003
Data are shown as mean ± standard deviation and number. P values were calculated by ANOVA’s test. For multiple comparison, Tukey procedure was done. *P < 0.05 com-
pared with lean group; 
†P < 0.05 obese vs overweight group. BMI, body mass index; BP, blood pressure; RBP4, retinol binding protein 4; HOMA-IR, homeostatic model assessment 
of insulin resistance.Rhie YJ, et al.  •  Serum Retinol Binding Protein 4 in Korean Children and Adolescents
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weight and lean groups. Systolic BP, RBP4, total cholesterol, and 
LDL cholesterol of obese group were significantly higher than 
those of lean group. Weight, BMI, abdominal circumference, 
RBP4, and LDL-cholesterol in overweight group were significant-
ly higher compared with lean group. There were no significant 
differences among lean, overweight, and obese groups for age, 
sex, puberty, height, diastolic BP, fasting glucose, adiponectin, 
triglyceride, and HDL-cholesterol. Serum RBP4 levels of obese 
and overweight groups were higher than those of lean group. 
Serum RBP4 level was higher in obese group than in overweight 
group, although it did not reach statistical significance. This ten-
dency was observed regardless of pubertal stage, although it did 
not reach statistical significance in late puberty group (Fig. 1). 
  The clinical and metabolic variables of prepuberty (n = 39), 
early (n = 32) and late puberty (n = 32) groups are shown in Table 
2. Late puberty group had significantly higher age, height, weight, 
and BMI than those of prepuberty and early puberty groups. 
Abdominal circumference, RBP4, fasting insulin, and HOMA-IR 
of late puberty group were significantly higher than those of pre-
puberty group. Age, height, weight, RBP4, fasting insulin, and 
HOMA-IR in early puberty group were significantly higher com-
pared with prepuberty group. Adiponectin of prepuberty group 
was significantly higher than that of late pubertal group. There 
were no significant differences among prepuberty, early and 
Table 2. Clinical and metabolic variables of prepuberty, early puberty and late puberty groups
Variables Prepuberty (n = 39) Early puberty (n = 32) Late puberty (n = 32) P value
Age (yr) 10.2 ± 1.9  12.7 ± 1.9*    14.8 ± 1.5*
,† < 0.001
Male (%) 71.8 53.1 50.0 0.124
Lean (%) 35.9 34.4 15.6 0.128
Height (cm) 139.0 ± 10.8  154.8 ± 11.6*  167.4 ± 8.8*
,† < 0.001
Weight (kg)   42.3 ± 13.0    57.6 ± 15.4*      74.7 ± 16.6*
,† < 0.001
BMI (kg/m
2) 21.5 ± 4.1 23.6 ± 4.2    26.4 ± 4.4*
,† < 0.001
Abdominal circumference (cm)   73.5 ± 12.6   80.3 ± 12.7    86.6 ± 12.5* < 0.001
Systolic BP (mmHg) 106.6 ± 10.0 112.1 ± 12.3 108.9 ± 13.1 0.145
Diastolic BP (mmHg) 64.1 ± 9.1 65.1 ± 9.8   61.8 ± 11.8 0.419
RBP4 (mg/L)   43.71 ± 15.31    58.53 ± 21.53*    58.13 ± 16.11* < 0.001
Fasting glucose (mM/L)   4.93 ± 0.44   4.95 ± 0.52   5.03 ± 0.41 0.614
Fasting insulin (mIU/L)   7.65 ± 4.90  14.76 ± 9.25*  13.57 ± 7.94* < 0.001
HOMA-IR   1.69 ± 1.14    3.30 ± 2.35*    3.06 ± 1.89* 0.001
Adiponectin (ng/mL)   24.61 ± 12.18   18.92 ± 11.48  16.07 ± 6.71* 0.011
Total cholesterol (mg/dL) 161.4 ± 33.6 150.6 ± 31.8 164.9 ± 28.5 0.170
Triglyceride (mg/dL)   97.6 ± 41.1 109.2 ± 66.2 102.6 ± 44.8 0.660
HDL-cholesterol (mg/dL)   49.2 ± 13.8   47.4 ± 12.8 46.3 ± 8.1 0.607
LDL-cholesterol (mg/dL)   87.4 ± 31.0   81.4 ± 28.8   97.3 ± 22.8 0.096
Data are shown as mean ± standard deviation and number. P values were calculated by ANOVA’s test. For multiple comparison, Tukey procedure was done. *P < 0.05 compared 
with prepuberty group; 
†P < 0.05 early puberty vs late puberty group. BMI, body mass index; BP, blood pressure; RBP4, retinol binding protein 4; HOMA-IR, homeostatic model 
assessment of insulin resistance.
Fig. 1. Serum retinol binding protein 4 (RBP4) and obesity in children and adolescents. 
Serum RBP4 levels of obese and overweight groups were compared with those of 
lean group according to pubertal stage. Serum RBP4 levels of obese and overweight 
groups were higher than those of lean group and this tendency was observed regardless 
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Fig. 2. Serum retinol binding protein 4 (RBP4) and puberty in children and adolescents. 
Serum RBP4 levels of puberty group were compared with those of prepuberty group 
according to degree of obesity. Compared with prepuberty group, serum RBP4 levels 
were higher in puberty group and this tendency was observed regardless of degree 
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Table 4. Results of multiple regression analysis to assess independent relationships 
between RBP4 and clinical and metabolic variables (R
2 = 0.477, P < 0.0001)
β P value
Age  -0.250 0.777




Systolic BP 0.070 0.609
Triglyceride 0.134 < 0.001
HOMA-IR -0.699 0.416
Unstandardized coefficients (β) and P values are presented. *Male = 0, female = 1; 
†Prepubertal = 0, pubertal = 1. BMI, body mass index; BP, blood pressure; RBP4, 
retinol binding protein 4; HOMA-IR, homeostatic model assessment of insulin resistance.
late puberty groups for sex, obesity, systolic, and diastolic BP, fast-
ing glucose, total cholesterol, triglyceride, HDL-cholesterol, and 
LDL-cholesterol. Serum RBP4 levels were significantly higher 
in early and late puberty groups than in prepuberty group and 
there was no significant difference in serum RBP4 level between 
early and late puberty groups. This tendency was observed re-
gardless of degree of obesity, although it did not reach statistical 
significance in lean group (Fig. 2).
  The correlations between serum RBP4 and other clinical and 
metabolic variables are shown in Table 3. Serum RBP4 was pos-
itively correlated with age, height, weight, BMI, abdominal cir-
cumference, systolic BP, fasting insulin, HOMA-IR, total choles-
terol, and triglyceride. Serum RBP4 was negatively correlated 
with adiponectin. 
  In the multiple linear regression analysis, RBP4 was found to 
be independently associated to pubertal stage, BMI and triglyc-
eride, whereas RBP4 demonstrated no significant correlation to 
age, sex, systolic BP, and HOMA-IR as shown in Table 4.
DISCUSSION
To the best of our knowledge, this is the first study on serum 
RBP4 levels according to degree of obesity and pubertal stage in 
Korean children and adolescents. In this study, we found that 
serum RBP4 level increased with progression of degree of obe-
sity and also increased in children with pubertal development. 
We also found that serum RBP4 level was correlated with indi-
ces of adiposity (BMI, abdominal circumference), insulin resis-
tance (fasting insulin, HOMA-IR), cardiovascular risk factors 
(systolic BP, triglyceride) and inversely with adiponectin in ac-
cordance with previous studies (8, 13, 18). However, most vari-
ables correlated with serum RBP4 in univariate analysis except 
for pubertal stage, BMI, and triglyceride were abolished after 
multiple linear regression analysis. 
  RBP4 has been postulated to be a determinant of insulin re-
sistance associated with obesity but, controversies exist as to 
whether RBP4 is an adipocyte-derived mediator of insulin re-
sistance or whether these associations are rather secondary to 
underlying obesity. Some previous studies reported a positive 
correlation between RBP4 levels and HOMA-IR in adults (8, 11). 
Lee et al. (18) found a positive correlation between RBP4 levels 
and HOMA-IR in non-obese adolescents, but not in obese ado-
lescents. In recent studies, RBP4 was also correlated with param-
eters of cardiovascular dysfunction (19). Furthermore, longitu-
dinal significant relationships between RBP4 levels, insulin lev-
els and HOMA-IR before and after weight loss were previously 
detected in a pediatric cohort (13). However other studies have 
failed to find such a correlation (10, 20). Kanaka-Gantenbein et 
al. (14) also found no significant correlation between RBP4 lev-
els and HOMA-IR and BMI SDS. 
  We found that RBP4 was independently associated with BMI 
but not with HOMA-IR in multiple regression analysis. Our re-
sults indicate that serum RBP4 level is significantly associated 
with adipose tissue mass and the relationship with insulin re-
sistance was secondary to an underlying association with obe-
sity. In a recent study, RBP4 mRNA and protein expression dur-
ing adipogenesis was analyzed. With progression of differentia-
tion from human preadipocytes into adipocytes, RBP4 produc-
tion increased by several magnitudes (21). These in vitro results 
suggest that RBP4 expression increases with increasing adipose 
tissue mass. Another previous study found a higher mRNA ex-
pression in obese compared with lean subjects (22). Our find-
ings are consistent with results of these studies.
  For studies in children and adolescents, pubertal develop-
ment should be considered because it is associated with chang-
es in body composition, endocrine and metabolic alterations. 
RBP4 was reported to correlated with increasing gonadotropin 
levels in healthy adult women (23). In addition, Bottner et al. (24) 
showed that serum adiponectin levels decreased with pubertal 
development in boys and androgens were closely correlated 
with adiponectin. We found that RBP4 levels were higher in pu-
Table 3. Correlations between RBP4 levels and other clinical and metabolic variables
RBP4
r P value 
Age (yr) 0.409 < 0.001
Height (cm) 0.412 < 0.001
Weight (kg) 0.541 < 0.001
BMI (kg/m
2) 0.567 < 0.001
Abdominal circumference (cm) 0.588 < 0.001
Systolic BP (mmHg) 0.218 0.027
Diastolic BP (mmHg) 0.081 0.418
Fasting glucose (mM/L) -0.085 0.393
Fasting insulin (mIU/L) 0.218 0.036
HOMA-IR 0.201 0.048
Adiponectin (ng/mL) -0.231 0.042
Total cholesterol (mg/dL) 0.235 0.017
Triglyceride (mg/dL) 0.429 < 0.001
HDL-cholesterol (mg/dL) 0.252 0.145
LDL-cholesterol (mg/dL) 0.155 0.134
Coefficients (r) and P values are calculated using Pearson’s correlation analysis. BMI, 
body mass index; BP, blood pressure; RBP4, retinol binding protein 4; HOMA-IR, 
homeostatic model assessment of insulin resistance.Rhie YJ, et al.  •  Serum Retinol Binding Protein 4 in Korean Children and Adolescents
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bertal group than in prepubertal group and pubertal stage was 
an independent predictor for RBP4 level in multiple linear re-
gression analysis. In contrast, no differences in circulating RBP4 
levels across different pubertal stages were observed in other 
study (25). The increase in fat mass and sex hormones during 
pubertal development may account for the difference in RBP4 
level between prepubetal and pubertal groups. Our findings sug-
gest that RBP4 is may be involved in insulin resistance of obese 
children during puberty. 
  As reported in previous studies (8, 18, 26, 27), serum RBP4 
levels were positively associated with triglyceride levels. This sug-
gests that RBP4 is likely to dysregulate fatty acid metabolism. 
Dysregulation of fatty acid metabolism is closely related with 
insulin resistance (28). However, it is not clear whether RBP4 
affect insulin action through a dysregulated fatty acid metabo-
lism.
  In previous studies, it has been suggested that sex-specific 
differences in RBP4 levels may exist, although the mechanism 
for this is not clear (5, 18). There were no significant sex-specific 
differences in RBP4 levels in this study, although the male sub-
jects had slightly higher RBP4 levels compared to the female 
subjects.
  The subjects of this study were limited to children and ado-
lescents because they represent a unique study population, as 
they present early stages of the pathogenic development and 
they are relatively free of co-morbidities and treatment common-
ly seen in adults. Because this was a cross sectional study, inter-
pretation of the results is limited. Therefore it is difficult to prove 
causality based on the findings. Further longitudinal studies are 
needed to confirm our results.
  In conclusion, serum RBP4 level is related with degree of adi-
posity and pubertal development in children and adolescent. 
There is a causal relation between serum RBP4 and adipose tis-
sue mass and serum RBP4 is a marker of adipose tissue mass. 
The association of RBP4 with insulin resistance is secondary to 
the underlying relation with adiposity. 
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Retinol binding protein 4 (RBP4) has been postulated to provide a new link between obesity and insulin resistance. We aimed to 
assess potential casual relationship between serum RBP4 and obesity-related insulin resistance by investigating serum RBP4 levels 
according to degree of obesity and pubertal stage. RBP4 is a marker of adipose tissue mass and the association of RBP4 with 
obesity-related insulin resistance appears to be secondary to the underlying relation with adipose tissue.